Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Our vision is to develop viral vector systems that deliver DNA code of ever increasing size and complexity into cells.
Daniel received his PhD at Purdue University (USA), carried out his post graduate studies at ETH Zürich (Switzerland), and has a two decade long track record in publishing, patenting, and marketing novel biotechnologies. Daniel has been co-founder of two previous startups and has received several prestigious entrepreneurship prizes including the Venture prize from McKinsey & Company and the W.A. de Vigier Award.
Imre received his PhD at MIT (USA) and carried out his post graduate studies at ETH Zürich (Switzerland), and is Professor and Wellcome Trust Senior Investigator in Bristol, UK. Imre is a trained x-ray crystallographer, and is also interested in synthetic biology.
Sonya studied management and finance at Purdue University (USA), and is a CPA with nearly 20 years of industry finance experience. Sonya is heading our operations in USA as Managing Director.
Alicia studied molecular biology at the University of Southern California (USA), and leads our sales and marketing team.
